XML 25 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2012
Dec. 31, 2011
Sales, net $ 53,438 $ 25,284 $ 106,297 $ 45,367
Cost of sales 8,799 3,680 16,606 6,636
Product recall costs 5,879   5,879  
Gross profit 38,760 21,604 83,812 38,731
Operating expenses:        
Sales and marketing 29,593 13,878 59,133 24,420
General and administrative 7,495 3,035 15,404 5,876
Research and development 742 312 1,257 546
Depreciation and amortization 443 97 681 177
Total operating expenses 38,273 17,322 76,475 31,019
Operating income 487 4,282 7,337 7,712
Other income (expense):        
Other income (expense), net (16) 26 (1) (13)
Change in fair value of derivative liabilities   3,142   3,946
Total other income (expense) (16) 3,168 (1) 3,934
Net income before income taxes 471 7,450 7,336 11,646
Income tax (expense) benefit (262) 1,309 (2,963) 837
Net income 209 8,759 4,373 12,483
Net income per share, basic $ 0.00 $ 0.09 $ 0.04 $ 0.13
Net income per share, diluted $ 0.00 $ 0.05 $ 0.03 $ 0.07
Weighted average shares, basic 113,449 99,409 112,158 99,184
Weighted average shares, diluted 127,131 121,231 126,046 121,003
Other comprehensive income, net of tax:        
Foreign currency translation adjustment 68 8 63 92
Other comprehensive income 68 8 63 92
Comprehensive income $ 277 $ 8,767 $ 4,162 $ 12,575